Winter Shift Stack

Risk: High

A flu-season stack in two stages, from the sick-day pairing to a TA1-only follow-up.

6-week cycle2 phases2 compounds
Best forRecovery 7/10
Cycle6wk
Compounds2
RiskHigh
3 min read

Composition: 2 Healing Peptides

1× Once daily1× Twice weekly

Overview

Winter Shift is a two-stage peptide stack built around a familiar flu-season question. Once the sick days pass, what changes? In the opening stage, thymosin alpha-1 (TA1) and LL-37 appear together. At the transition, LL-37 drops out and TA1 carries into a short follow-up.

The distinction matters when reading the six-week timeline. It shows which peptide belongs to each stage. Someone who feels better after a few days and someone whose fever returns both land in the same calendar block, but those symptoms call for different decisions.

Why this stack works

Why LL-37 appears in the opening stage. Cells lining the human airways release LL-37 onto the airway surface, where it forms part of the body's first line of defense against microbes. That local role explains the interest in LL-37 during respiratory illness. The airway study examined a peptide the body produces naturally. It did not test giving LL-37 to people with flu. Human airway study

Why TA1 carries into follow-up. TA1 has a different connection to flu research. In a randomized study, older men received a flu vaccine alongside either TA1 or a placebo. Researchers then measured how many participants had a fourfold rise in antibody levels. That measurement helps answer a question about vaccination. Whether someone who has just recovered will get sick again is a separate outcome. TA1 and flu vaccination study

Protocol timeline

2 phases · 6 weeks total

Timeline shows the 6-week cycle. Bars overlap when phases run concurrently. Click a bar to jump to its detail card.

The interactive timeline loads here. Phase details are available below.

Phase 1
Sick days · TA1 + LL-37
paired phaseWk 1–44wk

What’s in this stage. The proposed four-week block is the only part of Winter Shift that includes both peptides. LL-37 has a defined place here and drops out at the handoff. TA1 is the compound shared by both stages.

What matters on a sick day. Note when symptoms began, especially if you are at higher risk of complications. A clinician deciding whether to treat suspected flu needs that information right away. Antiviral medicines generally work best when started within the first two days. CDC flu treatment guidance

Phase 2
After recovery · TA1 only
follow-upWk 5–62wk

What changes at the handoff. Weeks five and six show TA1 alone. The two-week window gives the follow-up a clear endpoint. The stack has no recurring maintenance block through the rest of winter.

What to watch during recovery. A cough or fever that improves and then returns or worsens is a warning sign of a possible complication. Seek medical care promptly if that happens, even if the timeline still shows the follow-up stage. CDC flu warning signs

Compounds in this stack

2 linked · tap for full guide

How they work together

Combined effectiveness
Average 0–10 score per dimension across the compounds in this stack (simple mean per axis).
Pairwise synergies

Multipliers applied to the projection above when these compounds run together. Values > 1 indicate a bonus, < 1 a penalty.

PairTypeLeanFat lossRecovery
synergistic×1.00×1.00×1.15

Where to buy

grouped by vendor · fewest checkouts first

Real Peptides

Real Peptides

Our pickEverything in this stack · 2 items
Ships from USPeptide specialistVials, capsules & sprays

Affiliate link — we may earn a commission at no cost to you.

20% off — auto-applied at checkout

NextGenPeps

NextGenPeps

Everything in this stack · 2 items
Ships from USUS shipping only

Affiliate link — we may earn a commission at no cost to you.

10% off — use code at checkout

Swiss Chems

Swiss Chems

Everything in this stack · 2 items
Ships from USWidest catalogCapsules, powders & injectables

Affiliate link — we may earn a commission at no cost to you.

10% off — auto-applied at checkout

Conclusion

The six-week calendar ends with the TA1-only follow-up. Protection for the rest of flu season is a separate decision. Different influenza viruses can circulate in the same season, so recovering from one illness can still leave you susceptible to another. Annual vaccination remains the CDC’s main recommendation for seasonal protection. CDC seasonal flu prevention

Updated 2026-11-20